An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Luo, Zhaohui ^a   Zhang, Liyang ^a   Li, Zheng ^a   Li, Xiayu ^a   Li, Gang ^b   Yu, Haibo ^a   Jiang, Chen ^a   Dai, Yafei ^a   Guo, Xiaofang ^a   Xiang, Juanjuan ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENTARY DNA; KRUPPEL LIKE FACTOR 6; MICRORNA; MICRORNA 1; MICRORNA 141; MICRORNA 149; MICRORNA 18A; MICRORNA 18B; MICRORNA 203; MICRORNA 205; MICRORNA 206; MICRORNA 222; MICRORNA 29A; MICRORNA 34B; MICRORNA 34C; MICRORNA 429; MICRORNA 544; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN MYB; PROTEIN P53; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER STAGING; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; BIOLOGY; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; REPRODUCIBILITY;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION, GENETIC;

EID: 84862796512     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-3     Document Type: Article

References (49)

1. Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM, Head Neck 2008 30 7 946 963 10.1002/hed.20833 18446839 (Pubitemid 352008957)
2. Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome. Lin JC, Liao SK, Lee EH, Hung MS, Sayion Y, Chen HC, Kang CC, Huang LS, Cherng JM, J Biomed Sci 2009 16 105 10.1186/1423-0127-16-105 19930697
3. Distant metastasis of undifferentiated carcinoma of nasopharyngeal type. Tao Y, Bidault F, Bosq J, Bourhis J, Onkologie 2008 31 11 574 575 10.1159/000164934 19145087
4. Current understanding and management of nasopharyngeal carcinoma. Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K, Auris Nasus Larynx 2011
5. miRNA control of tumor cell invasion and metastasis. Baranwal S, Alahari SK, Int J Cancer 2009 126 6 1283 1290
6. microRNA evaluation of unknown primary lesions in the head and neck. Barker EV, Cervigne NK, Reis PP, Goswami RS, Xu W, Weinreb I, Irish JC, Kamel-Reid S, Mol Cancer 2009 8 127 20028561
7. MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers. Nugent M, Miller N, Kerin MJ, Eur J Surg Oncol 2011 37 8 649 654 10.1016/j.ejso.2011.05.005 21632200
8. RAS is regulated by the let-7 microRNA family. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ, Cell 2005 120 5 635 647 10.1016/j.cell.2005.01.014 15766527 (Pubitemid 40343076)
9. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA, Nat Biotechnol 2010 28 4 341 347 10.1038/nbt.1618 20351690
10. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al. J Cell Sci 2011 124 Pt 17 2997 3005 21878506
11. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al. Cancer Res 2011 71 6 2381 2391 10.1158/0008-5472.CAN-10-2754 21385904
12. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF, et al. Cancer Res 2011 71 1 225 233 10.1158/0008-5472.CAN-10-1850 21199804
13. MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells. Ji Y, He Y, Liu L, Zhong X, FEBS Lett 2010 584 5 961 967 10.1016/j.febslet.2010.01.036 20100477
14. MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L, Pan Q, He ML, Li XP, Cancer Lett 2010 299 1 29 36 10.1016/j.canlet.2010.07.021 20732742
15. MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. Wong TS, Man OY, Tsang CM, Tsao SW, Tsang RK, Chan JY, Ho WK, Wei WI, To VS, J Cancer Res Clin Oncol 2010 137 3 415 422 20440510
16. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, Wu M, Zhou M, Shen S, Niu Z, et al. Carcinogenesis 2010 31 4 559 566 10.1093/carcin/bgp335 20053927
17. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, Kung HF, Lin MC, Biochem Biophys Res Commun 2009 391 1 535 541 19931509
18. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY, Cancer 2011
19. EBV-encoded miRNAs. Barth S, Meister G, Grasser FA, Biochim Biophys Acta 2011 1809 631 640 21640213
20. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS, Chen HC, PLoS One 2010 5 9 ii: e12745
21. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Cho WC, Mol Cancer 2007 6 1 17199893
22. EBV-encoded miRNAs. Barth S, Meister G, Grasser FA, Biochim Biophys Acta 2011 1809 11-12 631 640 21640213
23. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Cho WC, Int J Biochem Cell Biol 2010 42 8 1273 1281 10.1016/j.biocel.2009.12.014 20026422
24. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, Hayward SD, Proc Natl Acad Sci USA 2007 104 41 16164 16169 10.1073/pnas.0702896104 17911266 (Pubitemid 350099379)
25. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ, Br J Cancer 2009 100 6 1002 1011 10.1038/sj.bjc.6604948 19293812
26. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P, Proc Natl Acad Sci USA 2008 105 15 5874 5878 10.1073/pnas. 0801130105 18390668 (Pubitemid 351758465)
27. microRNA expression profiling of nasopharyngeal carcinoma. Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen Kh H, Li Y, Oncol Rep 2011 25 5 1353 1363 21373758
28. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, Cheng Y, Jin Z, Yang J, Agarwal R, et al. Inflamm Bowel Dis 2010 17 1 221 231
29. PuTmiR: a database for extracting neighboring transcription factors of human microRNAs. Bandyopadhyay S, Bhattacharyya M, BMC Bioinformatics 2010 11 190 10.1186/1471-2105-11-190 20398296
30. MicroRNA promoter element discovery in Arabidopsis. Megraw M, Baev V, Rusinov V, Jensen ST, Kalantidis K, Hatzigeorgiou AG, RNA 2006 12 9 1612 1619 10.1261/rna.130506 16888323 (Pubitemid 44316025)
31. MicroRNAs in cancer-from research to therapy. Cho WC, Biochim Biophys Acta 2010 1805 2 209 217 19931352
32. [A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma]. Mao YP, Li WF, Chen L, Sun Y, Liu LZ, Tang LL, Cao SM, Lin AH, Hong MH, Lu TX, et al. Ai Zheng 2009 28 10 1022 1028 19799808
33. [Comment for the Chinese 2008 staging system for nasopharyngeal carcinoma]. Sun Y, Ma J, Ai Zheng 2009 28 10 1016 1021 19799807
34. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y, Nat Rev Cancer 2008 8 1 37 49 10.1038/nrc2294 18097463
35. A random variance model for detection of differential gene expression in small microarray experiments. Wright GW, Simon RM, Bioinformatics 2003 19 18 2448 2455 10.1093/bioinformatics/btg345 14668230 (Pubitemid 38016644)
36. Metastasis predictive signature profiles pre-exist in normal tissues. Yang H, Crawford N, Lukes L, Finney R, Lancaster M, Hunter KW, Clin Exp Metastasis 2005 22 7 593 603 10.1007/s10585-005-6244-6 16475030 (Pubitemid 43234644)
37. Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles. Prieto C, Risueno A, Fontanillo C, De las Rivas J, PLoS One 2008 3 12 3911 10.1371/journal.pone.0003911 19081792
38. Transcription factor modularity in a gene-centered C. elegans core neuronal protein-DNA interaction network. Vermeirssen V, Barrasa MI, Hidalgo CA, Babon JA, Sequerra R, Doucette-Stamm L, Barabasi AL, Walhout AJ, Genome Res 2007 17 7 1061 1071 10.1101/gr.6148107 17513831 (Pubitemid 47026353)
39. Discovery of microRNA-mRNA modules via population-based probabilistic learning. Joung JG, Hwang KB, Nam JW, Kim SJ, Zhang BT, Bioinformatics 2007 23 9 1141 1147 10.1093/bioinformatics/btm045 17350973 (Pubitemid 47050566)
40. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS, Chen HC, PLoS One 2010 5 9
41. Complete characterization of the microRNAome in a patient with acute myeloid leukemia. Ramsingh G, Koboldt DC, Trissal M, Chiappinelli KB, Wylie T, Koul S, Chang LW, Nagarajan R, Fehniger TA, Goodfellow P, et al. Blood 2010 116 24 5316 5326 10.1182/blood-2010-05-285395 20876853
42. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Park SY, Lee JH, Ha M, Nam JW, Kim VN, Nat Struct Mol Biol 2009 16 1 23 29 10.1038/nsmb.1533 19079265
43. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Xu H, Cheung IY, Guo HF, Cheung NK, Cancer Res 2009 69 15 6275 6281 10.1158/0008-5472.CAN-08-4517 19584290
44. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et al. J Urol 2009 183 2 743 7451
45. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, Carvalho B, Meijer GA, Br J Cancer 2009 101 4 707 714 10.1038/sj.bjc.6605037 19672269
46. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells. Adams BD, Cowee DM, White BA, Mol Endocrinol 2009 23 8 1215 1230 10.1210/me.2009-0062 19423651
47. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, et al. Biochem Biophys Res Commun 2009 391 1 73 77 19896465
48. Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bornman D, Zhang S, et al. BMC Med Genomics 2011 4 8 10.1186/1755-8794-4-8 21241464
49. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. Shalgi R, Lieber D, Oren M, Pilpel Y, PLoS Comput Biol 2007 3 7 131 10.1371/journal.pcbi.0030131 17630826 (Pubitemid 47196171)